These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9850625)

  • 1. [Can exercise be harmful?].
    Lund-Olesen K
    Ugeskr Laeger; 1998 Nov; 160(49):7147-8. PubMed ID: 9850625
    [No Abstract]   [Full Text] [Related]  

  • 2. Superoxide dismutase may lead to cytoskeletal abnormalities and amyotrophic lateral sclerosis.
    Brenner S
    Ann Neurol; 2008 Sep; 64(3):357-8; author reply 358. PubMed ID: 18409199
    [No Abstract]   [Full Text] [Related]  

  • 3. MS: ALS, MS, MD--what's the difference?
    Plank C
    Am J Nurs; 1980 Feb; 80(2):282-3. PubMed ID: 6898393
    [No Abstract]   [Full Text] [Related]  

  • 4. The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis.
    Centonze D; Rossi S; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Int Rev Neurobiol; 2007; 82():171-86. PubMed ID: 17678961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of toxicity of serum from multiple sclerosis and motor neurone disease on myelin in vitro.
    Field EJ; Hughes D
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:563-7. PubMed ID: 5373042
    [No Abstract]   [Full Text] [Related]  

  • 6. The urokinase system of plasminogen activator plays a role in amyotrophic lateral sclerosis (ALS) pathogenesis.
    Beal MF
    Exp Neurol; 2008 Jun; 211(2):332-3. PubMed ID: 18423450
    [No Abstract]   [Full Text] [Related]  

  • 7. Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord.
    Schirmer L; Albert M; Buss A; Schulz-Schaeffer WJ; Antel JP; Brück W; Stadelmann C
    Ann Neurol; 2009 Nov; 66(5):698-704. PubMed ID: 19938172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and neurotoxicity.
    Sayre LM; Perry G; Smith MA
    Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle atrophy associated with multiple sclerosis: a benign condition or the onset of amyotrophic lateral sclerosis?
    Allen JA; Stein R; Baker RA; Royden Jones H
    J Clin Neurosci; 2008 Jun; 15(6):706-8. PubMed ID: 18395451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system.
    Vickers JC; King AE; Woodhouse A; Kirkcaldie MT; Staal JA; McCormack GH; Blizzard CA; Musgrove RE; Mitew S; Liu Y; Chuckowree JA; Bibari O; Dickson TC
    Brain Res Bull; 2009 Oct; 80(4-5):217-23. PubMed ID: 19683034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal enzymes in motor neurone disease and multiple sclerosis.
    Yates CM; Wilson H; Davidson D
    Clin Chim Acta; 1973 Sep; 47(3):397-402. PubMed ID: 4744831
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of cerebrocranial injuries in the development of manifest spontaneous diseases of the nervous system].
    Radomska M
    Neuropatol Pol; 1975; 13(3-4):327-32. PubMed ID: 1207898
    [No Abstract]   [Full Text] [Related]  

  • 13. Manganese superoxide dismutase levels are elevated in a proportion of amyotrophic lateral sclerosis patient cell lines.
    McEachern G; Kassovska-Bratinova S; Raha S; Tarnopolsky MA; Turnbull J; Bourgeois J; Robinson B
    Biochem Biophys Res Commun; 2000 Jun; 273(1):359-63. PubMed ID: 10873611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis.
    Vonk WI; Klomp LW
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1322-8. PubMed ID: 19021549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
    Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
    Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of exercise in amyotrophic lateral sclerosis.
    Chen A; Montes J; Mitsumoto H
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):545-57, ix-x. PubMed ID: 18625415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.
    Gonzalez de Aguilar JL; Dupuis L; Oudart H; Loeffler JP
    Biomed Pharmacother; 2005 May; 59(4):190-6. PubMed ID: 15862714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of hereditary factors in 2 diseases of unknown etiology: amyotrophic lateral sclerosis & multiple sclerosis].
    BARBIZET J
    Concours Med; 1958 Dec; 80(50):5369-72. PubMed ID: 13609147
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
    Gomes C; Keller S; Altevogt P; Costa J
    Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALS combination treatment. Drug cocktails.
    Rosenfeld J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():115-7. PubMed ID: 15512890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.